Abstract: Objective This article introduces the existence situation of "unlabeled uses" and related policy at home and abroad to be able to cause community-wide concern and promote the safe use of drugs. MethodsAccess to relevant literature in recent years, thought analysis, summary and synthesis is reviewed. Resultsand ConclusionThere are no clear legislatives about "unlabeled uses" in China. medical institution and management agencies need to work hard together. Management department needs to accelerate the legislative process. Physicians and pharmacists need to strengthen self-discipline to effectively guarantee public safety.

Key words: unlabeled uses, consensus, medication safety